sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
2-Sep-2014 13:04
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 576-600 out of 893.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>

Public Release: 8-May-2013
Journal of Infectious Diseases
New malaria tool shows which kids at greatest risk
Researchers at Michigan State University have identified a test that can determine which children with malaria are likely to develop cerebral malaria, a much more life-threatening form of the disease. The screening tool could be a game-changer in resource-limited rural health clinics where workers see hundreds of children with malaria each day and must decide which patients can be sent home with oral drugs and which need to be taken to hospitals for more comprehensive care.
National Institutes of Health

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University

Public Release: 7-May-2013
New advocates join global effort to eliminate neglected tropical diseases
Today, the Global Network for Neglected Tropical Diseases (Global Network), a major initiative of the Sabin Vaccine Institute, announced His Excellency, President Alvaro Arzú Irigoyen of Guatemala (1996-2000), His Excellency, President Ricardo Lagos Escobar of Chile (2000-2006) and former Pan American Health Organization Director Dr. Mirta Roses Periago as the organization's newest Neglected Tropical Disease Special Envoys.

Contact: Richard Hatzfeld
Richard.hatzfeld@sabin.org
202-842-5025
Sabin Vaccine Institute

Public Release: 7-May-2013
TB, HIV and malaria vaccine research gets major boost
Aeras, a nonprofit biotech advancing TB vaccines for the world, the University of Oxford and Okairos, a biopharmaceutical company specializing in T-cell vaccines, today announced a $2.9 million grant to Aeras in support of a collaboration among the three parties to support the development of vaccines against tuberculosis, HIV and malaria.
Bill and Melinda Gates Foundation

Contact: Annmarie Leadman
aleadman@aeras.org
240-599-3018
Aeras

Public Release: 7-May-2013
Biophysical Journal
New insights into Ebola infection pave the way for much-needed therapies
The Ebola virus is among the deadliest viruses on the planet, killing up to 90 percent of those infected. A study published in the Biophysical Journal reveals how the most abundant protein making up the Ebola virus -- viral protein 40 -- allows the virus to leave host cells and spread infection to other cells throughout the human body. The findings could lay the foundation for the development of new drugs and strategies for fighting Ebola infection.

Contact: Mary Beth O'Leary
moleary@cell.com
617-397-2802
Cell Press

Public Release: 6-May-2013
Proceedings of the National Academy of Sciences
Competing antibodies may have limited the protection achieved in HIV vaccine trial in Thailand
Continuing analysis of an HIV vaccine trial undertaken in Thailand is yielding additional information about how immune responses were triggered and why the vaccine did not protect more people.
Bill & Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases, US Army Medical Research and Material Command

Contact: Sarah Avery
sarah.avery@duke.edu
919-660-1306
Duke University Medical Center

Public Release: 6-May-2013
Hepatology
New antiviral treatment could significantly reduce global burden of hepatitis C
Around 150 million people globally are chronically infected with the hepatitis C virus (HCV) -- a major cause of liver disease and the fastest growing cause of liver transplantation and liver cancer. New prevention strategies are urgently required as people are continuing to be infected with HCV. Findings, published in Hepatology, reveal the impact of a new antiviral treatment that could potentially reduce HCV rates in some cities affected by chronic HCV prevalence by half over 15 years.

Contact: Caroline Clancy
caroline.clancy@bristol.ac.uk
44-011-792-88086
University of Bristol

Public Release: 5-May-2013
GCP21 Strategic Meeting
Scientists alarmed by rapid spread of Brown Streak Disease in cassava
Cassava experts are reporting new outbreaks and the increased spread of Cassava Brown Streak Disease or CBSD, warning that the rapidly proliferating plant virus could cause a 50 percent drop in production of a crop that provides a significant source of food and income for 300 million Africans.

Contact: Michelle Geis
mgeis@burnesscommunications.com
301-280-5712
Burness Communications

Public Release: 4-May-2013
Pediatric Academic Societies Annual Meeting
Environmental Health Perspectives
Toxic waste sites cause healthy years of life lost
Toxic waste sites with elevated levels of lead and chromium cause a high number of "healthy years of life lost" in individuals living near 373 sites located in India, Philippines and Indonesia, according to a study by a Mount Sinai researcher published online today in Environmental Health Perspectives.
Blacksmith Institute

Contact: Renatt Brodsky
Renatt.Brodsky@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine

Public Release: 1-May-2013
New federal investment could save millions of lives
Thanks to new federal funding, low-cost, easily accessible technology invented by a Simon Fraser University engineering professor and his graduate students is closer to helping to save millions of infant lives. The lab-on-a-chip, designed by Ash Parameswaran and his students, is among 102 global research projects receiving $100,000 each through the federal government's Stars in Global Health program.
Grand Challenges Canada

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University

Public Release: 1-May-2013
Rice U. professors share Lemelson-MIT award, donate prize money
Rice University bioengineering professors Rebecca Richards-Kortum and Maria Oden, the winners of the 2013 $100,000 Lemelson-MIT Award for Global Innovation, are dedicating their prize money toward the construction of a new neonatal nursery at the African hospital that has helped implement Rice's low-cost, student-designed health care technologies since 2007. The nursery will improve patient care at Queen Elizabeth Central Hospital in Blantyre, Malawi, and support technology innovation through Rice's Day One project.
Lemelson-MIT Program

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University

Public Release: 30-Apr-2013
Proceedings of the National Academy of Sciences
Economics influence fertility rates more than other factors
Based on a recent study by a University of Missouri anthropologist, economic changes have the greatest impact on reducing family size, and thus slowing population growth, compared to other factors. Understanding the causes of declining birth rates may lead to improved policies designed to influence fertility and result in reduced competition for food, water, land and wealth.
National Science Foundation

Contact: Tim Wall
walltj@missouri.edu
573-882-3346
University of Missouri-Columbia

Public Release: 29-Apr-2013
Dissertations and Features
Warning system predicts outbreaks of dengue fever
With the help of a warning system which measures the risk of dengue incidence using precipitation and air temperature, it is possible to forecast the outbreak of dengue fever up to 16 weeks in advance. This is what Yien Ling Hii concludes in the dissertation she is defending at Umeĺ University in Sweden on 3 May.

Contact: Yien Ling Hii
yienling.hii@umu.se
46-073-692-1345
Umea University

Public Release: 29-Apr-2013
Inventive: 102 bold new global health ideas win Grand Challenges Canada funding
59 innovators in 13 low and middle income countries and 43 in Canada will share $10.9 million in Canadian seed funding to pursue bold, creative ideas for tackling health problems in resource-poor parts of the world. The grants will advance 102 out-of-the-box innovations in remote diagnostics and monitoring, health protection, drug and vaccine development and accessibility, and other key health areas.

Contact: Terry Collins
tc@tca.tc
416-538-8712
Sandra Rotman Centre for Global Health

Public Release: 26-Apr-2013
International Liver Congress 2013
Developments in TACE and SIRT treatment in patients
Data from a number of clinical trials presented today at the International Liver Congress™ 2013 shed new light on the use of TACE and SIRT in the treatment of hepatocellular carcinoma.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 26-Apr-2013
Gastroenterology
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
Gilead Sciences

Contact: Joseph Carey
jcarey@txbiomed.org
210-258-9437
Texas Biomedical Research Institute

Public Release: 25-Apr-2013
A*STAR, Veredus create market's first lab-on-chip to detect multiple tropical infectious diseases
The Agency for Science, Technology and Research and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.
Agency for Science, Technology and Research

Contact: Dr. Sarah Chang
chang_kai_chen@a-star.edu.sg
65-682-66442
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 25-Apr-2013
International Liver Congress 2013
New studies prove lethal link between alcohol, weight
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
Direct-acting antivirals now ready for prime time
New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents for the treatment of hepatitis C.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-790-013-8904
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
NASH diagnosis set to improve with non-invasive tool
A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis diagnosis.

Contact: Dimple Natali
easlpressoffice@cohnwolfe.com
44-079-001-38904
European Association for the Study of the Liver

Public Release: 23-Apr-2013
AfriCoLeish receives funding boost from European Union
Research and development project, AfriCoLeish, is supported by the European Union Seventh Framework Programme through a grant of €3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.
European Union

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 17-Apr-2013
7th Annual Sickle Cell Disease Research and Educational Symposium
Anti-sickling therapies should be focus for sickle cell science
Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University

Public Release: 17-Apr-2013
Science Translational Medicine
HIV-infected moms who breastfeed exclusively have lower levels of virus in breast milk
HIV-infected women in sub-Saharan Africa who fed their babies exclusively with breast milk for more than the first four months of life had the lowest risk of transmitting the virus to their babies through breast milk. Women who stopped breast feeding earlier than four months had the highest concentrations of HIV in their breast milk, and those who continued to breastfeed, but not exclusively, had concentration levels in-between the two practices.

Contact: stephanie berger
sb2247@columbia.edu
212-305-4372
Columbia University's Mailman School of Public Health

Public Release: 16-Apr-2013
mBio
TGen-led study discovers dramatic changes in bacteria following male circumcision
Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute.
National Institutes of Health, Northern Arizona University

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute

Public Release: 16-Apr-2013
mBio
Haiti cholera mutations could lead to more severe disease
The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 15-Apr-2013
Proceedings of the National Academy of Sciences
La Jolla Institute's surprising finding could alter the face of dengue vaccine development
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine.

Contact: Bonnie Ward
contact@liai.org
619-303-3160
La Jolla Institute for Allergy and Immunology

Showing releases 576-600 out of 893.

<< < 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 > >>